Galderma Group AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
$22.9B
Website
http://www.galderma.com/

A Multi-Center Study Of CD07743 for the Improvement of Lateral Canthal Lines (CROW'S FEET)

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-03-03
Last Posted Date
2020-05-01
Lead Sponsor
Galderma R&D
Target Recruit Count
335
Registration Number
NCT01308060

Macrolane VRF30 for Enhancement of Shape and Fullness of Female Breast

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-02-18
Last Posted Date
2022-09-28
Lead Sponsor
Galderma R&D
Target Recruit Count
71
Registration Number
NCT01299532
Locations
🇫🇷

Sainte Anne, Paris, France

🇫🇷

L'Institute du Sein, Paris, France

🇸🇪

Plastikkirurggruppen, Stockholm, Sweden

and more 2 locations

Different Volumes of Durolane in Knee OA

First Posted Date
2010-12-23
Last Posted Date
2022-09-22
Lead Sponsor
Galderma R&D
Target Recruit Count
68
Registration Number
NCT01265459
Locations
🇸🇪

Christian Akermark, Stockholm, Sweden

🇸🇪

Torsten Adalberth, Malmo, Sweden

🇸🇪

Johan Isacson, Upplands Vasby, Sweden

Macrolane Retrospective Study

First Posted Date
2010-10-19
Last Posted Date
2022-08-26
Lead Sponsor
Galderma R&D
Target Recruit Count
93
Registration Number
NCT01223963
Locations
🇸🇪

Stureplanskliniken, Stockholm, Sweden

🇸🇪

Akademikliniken, Stockholm, Sweden

Macrolane Prospective Survey

First Posted Date
2010-10-18
Last Posted Date
2022-08-25
Lead Sponsor
Galderma R&D
Registration Number
NCT01223066
Locations
🇸🇪

Akademikliniken, Stockholm, Sweden

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-10-01
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
20
Registration Number
NCT01213199
Locations
🇺🇸

Manisha PATEL, Baltimore, Maryland, United States

Durolane Versus Methylprednisolone in Knee Osteoarthritis

First Posted Date
2010-09-27
Last Posted Date
2022-08-25
Lead Sponsor
Galderma R&D
Target Recruit Count
442
Registration Number
NCT01209364
Locations
🇨🇦

Nexus Clinical Research, St John´s, Newfoundland and Labrador, Canada

🇨🇦

Centre de Rhumatologie St-Louis, Saint-Foy, Quebec, Canada

🇨🇦

Alberta Bone & Joint Health Institute, Calgary, Alberta, Canada

and more 19 locations

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

First Posted Date
2010-09-27
Last Posted Date
2022-08-01
Lead Sponsor
Galderma R&D
Target Recruit Count
30
Registration Number
NCT01209949
Locations
🇺🇸

Thomas J. Stephens and Associates, Carrollton, Texas, United States

Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds

First Posted Date
2010-09-20
Last Posted Date
2023-07-25
Lead Sponsor
Galderma R&D
Target Recruit Count
171
Registration Number
NCT01205048
Locations
🇺🇸

Dermatology Research Institute, Coral Gables, Florida, United States

🇺🇸

Skin Care & Laser Physicians of Beverly Hills, Los Angeles, California, United States

🇺🇸

Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States

and more 9 locations

Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds

First Posted Date
2010-09-20
Last Posted Date
2023-10-23
Lead Sponsor
Galderma R&D
Target Recruit Count
162
Registration Number
NCT01205061
Locations
🇺🇸

Galderma research site, Plano, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath